A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma: evaluation of clinical and immunologic response

被引：0
作者：
Katrien De Wolf
Vibeke Kruse
Nora Sundahl
Mireille van Gele
Ines Chevolet
Reinhart Speeckaert
Lieve Brochez
Piet Ost
机构：
[1] University Hospital Ghent,Department of Radiation
[2] University Hospital Ghent,Oncology
[3] University Hospital Ghent,Department of Medical Oncology
来源：
Journal of Translational Medicine | / 15卷
关键词：
Cancer immunotherapy; Stereotactic body radiotherapy; Metastatic melanoma; Biomarkers; Immune monitoring;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 34 条
  • [31] Patterns of response to anti-PD-1 treatment: an exploratory comparison of four radiological response criteria and associations with overall survival in metastatic melanoma patients
    Khoja, Leila
    Kibiro, Minnie
    Metser, Ur
    Gedye, Craig
    Hogg, David
    Butler, Marcus O.
    Atenafu, Eshetu G.
    Joshua, Anthony M.
    BRITISH JOURNAL OF CANCER, 2016, 115 (10) : 1186 - 1192
  • [32] Hypofractionated radiotherapy plus PD-1 antibody and SOX chemotherapy as second-line therapy in metastatic pancreatic cancer: a single-arm, phase II clinical trial
    Wang, Qin
    Tong, Fan
    Qiao, Li
    Qi, Liang
    Sun, Yi
    Zhu, Yahui
    Ni, Jiayao
    Liu, Juan
    Kong, Weiwei
    Liu, Baorui
    Du, Juan
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (10)
  • [33] Illustrative cases for monitoring by quantitative analysis of BRAF/NRAS ctDNA mutations in liquid biopsies of metastatic melanoma patients who gained clinical benefits from anti-PD1 antibody therapy
    Seremet, Teofila
    Planken, Simon
    Schreuer, Max
    Jansen, Yanina
    Delaunoy, Melanie
    El Housni, Hakim
    Lienard, Danielle
    Del Marmol, Veronique
    Heimann, Pierre
    Neyns, Bart
    MELANOMA RESEARCH, 2018, 28 (01) : 65 - 70
  • [34] The role of adaptive planning in margin-reduced, MRI-guided stereotactic body radiotherapy to the prostate bed following radical prostatectomy: Post-hoc analysis of a phase II clinical trial
    Nikitas, John
    Smith, Lauren M.
    Gao, Yu
    Ma, Ting Martin
    Sachdeva, Ankush
    Yoon, Stephanie M.
    Jiang, Tommy
    Low, Daniel A.
    Ballas, Leslie K.
    Steinberg, Michael L.
    Cao, Minsong
    Kishan, Amar U.
    RADIOTHERAPY AND ONCOLOGY, 2023, 183
1234